Month: August 2025

American Shared Hospital Services Reports Second Quarter 2025 Financial Results

Written by Customer Service on August 13, 2025. Posted in Public Companies.

Total Revenue Increased 16% Sequentially Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing and direct patient care services segments, today announced financial results for the second quarter ended June 30, 2025. Key Financial HighlightsQ2 2025 Revenue Increased 16% Sequentially Compared to Q1 2025 and Increased 0.2% Compared to Q2 2024 Q2 2025 Gamma Knife Revenue Increased 25% Sequentially and Decreased 5% Compared to Q2 2024 Q2 2025 LINAC Revenue Increased 7% Sequentially and Increased 34% Compared to Q2 2024 Q2 2025 Proton Beam Radiation Therapy Revenue Increased 17%...

Rego Payment Architectures, Inc. and Aambé Financial Announce Partnership to Expand Financial Inclusion Across Indian Country

Written by Customer Service on August 13, 2025. Posted in Public Companies.

Strategic alliance brings REGO’s family banking platform to all 574 federally recognized tribes, with 6 million members (not including spouses and children), starting with its youth banking product and expanding into elder care and fractional investing BLUE BELL, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) — Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), the leading white-label family financial lifecycle solution platform, today announced a strategic partnership with Aambé Financial to bring REGO’s generational banking tools to tribal nations across the United States. Aambé Financial, a Native-led organization rooted in economic empowerment, will work with REGO to introduce its youth banking, elder financial care, and fractional investment offerings to tribal governments, enterprises, and families. This alliance reflects a shared...

Correction: Form 8.3 – Tritax Big Box Reit Plc

Written by Customer Service on August 13, 2025. Posted in Mergers And Acquisitions.

AMENDED DISCLOSURE – PLEASE REFER TO SECTION 3(a) 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Tritax Big Box REIT Plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date...

Endeavour Silver Announces Q2 2025 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) announces its financial and operating results for the three and six months ended June 30, 2025. All dollar amounts are in US dollars ($). “We are pleased with Endeavour’s strong performance this quarter, highlighted by increased silver equivalent production, robust revenue growth, and the successful integration of Minera Kolpa into our portfolio,” said Dan Dickson, Chief Executive Officer. “Our team delivered solid operating results, achieving higher sales at favorable market prices while maintaining costs below guidance. The completion of the Minera Kolpa acquisition has enhanced the Company’s growth profile, and with Terronera nearing commercial production, we are transforming our operational...

Gildan and HanesBrands Agree to Combine To Create a Global Basic Apparel Leader

Written by Customer Service on August 13, 2025. Posted in Mergers And Acquisitions.

(all amounts are in U.S. dollars except where otherwise indicated)(1) Please refer to “Non-GAAP financial measures and related ratios” in this press release(2) Enterprise value is calculated as fully diluted equity value, plus financial debt, plus underfunded pension liabilities, less cash and equivalents Combination will create a global basic apparel leader, with access to iconic innerwear brands and a further strengthened low-cost vertically integrated manufacturing network Highly complementary acquisition expands Gildan’s scale, increasing the strength of our business in basic apparel Proven operational model expected to enable the realization of at least $200 million of annual run-rate cost synergies within three years of closing: ~$50 million in 2026, ~$100 million in 2027, ~$50 million in 2028 Expected...

Perspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2025 Results

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

[212Pb]VMT-α-NET study update presented at the 2025 ASCO Annual Meeting, based on updated interim results from a Phase 1/2a study in neuroendocrine tumors. As of the April 30, 2025 data cut-off date:Four of the initial seven patients enrolled in Cohort 2 experienced objective responses as defined by RECIST v1.1. Three of those patients experienced confirmed response and remained in response. One new first response was subject to confirmation. Seven of nine patients in Cohorts 1 and 2 remained free from disease progression after more than one year of follow-up [212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities and no discontinuations due to adverse events observed among a total of 42 patients who received at least one treatmentReached alignment with FDA in June to open Cohort 3 (6.0 mCi)...

BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates

Written by Customer Service on August 13, 2025. Posted in Public Companies.

Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patients; Planning underway for potential registrational study Nature Communications publication of new BX004 Phase 1b/2a data demonstrated further ~500-fold (2.7 log₁₀)2 bacterial reduction versus placebo with no detectable emergence of resistance observed, highlighting strength of BiomX platform capabilities Phase 2b trial of BX004 in Cystic Fibrosis (CF) has successfully commenced patient dosing; FDA feedback on real-world evidence strategy expected in H2 2025; Company expects to report topline results in Q1 2026 BiomX will host a conference call and webcast today at 8:00 AM ET NESS ZIONA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company...

K92 Mining Strengthens Community Affairs and External Relations Leadership with Key Appointments

Written by Customer Service on August 13, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQB: KNTNF) is pleased to announce the promotion of Stanley Komunt, as Vice President – Community Affairs and External Relations, and the appointment of Felix Kipalan, as General Manager – Community Affairs. Mr. Komunt is an experienced community and government relations leader with over 25 years of experience in the mining industry, specializing in corporate governance, stakeholder engagement, and risk management. Mr. Komunt joined K92 in early 2025, most recently holding the position of General Manager, Community Affairs and External Relations. From 2018 to 2024, he served as Country Manager for Newcrest Mining Limited and, following its acquisition, with Newmont Corporation in Papua New Guinea, where he played...

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

Written by Customer Service on August 13, 2025. Posted in Public Companies.

MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) reviewed the study design, endpoints and planned statistical analysis of the ongoing pivotal confirmatory OCU410ST Phase 2/3 GARDian3 clinical trial for Stargardt disease and provided acceptability of a single U.S.-based trial for submission of a Marketing Authorization Application (MAA). EMA provided this opinion based on safety and tolerability that OCU410ST demonstrated in the Phase 1 GARDian trial, including 48% slower lesion growth and statistically significant (p=0.031) and clinically meaningful improvement of nearly 2-line/9-letter...

Hudbay Delivers Strong Second Quarter 2025 Results

Written by Customer Service on August 13, 2025. Posted in Earnings Releases And Operating Results.

TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today released its second quarter 2025 financial results. All amounts are in U.S. dollars, unless otherwise noted. “We delivered another quarter of significant free cash flow generation driven by continued industry-leading cost margins and diversified exposure to copper and gold,” said Peter Kukielski, President and Chief Executive Officer. “Our strong financial performance enabled us to further reduce long-term debt, invest in our many high-return growth projects and further strengthen our balance sheet to its best position in over a decade. With the strong performance in the first half of the year, we are reaffirming our full year consolidated production guidance and are favourably tracking well below our full year...

Month: August 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals